Successful treatment of polycystic ovary syndrome with spironolactone or bromocriptine

Blum I; Kaufman H; Marilus R; Rusecki Y; Chovers I

Therapeutics · Ovulation Agents

Successful treatment of polycystic ovary syndrome with spironolactone or bromocriptine

Blum I, Kaufman H, Marilus R, Rusecki Y, Chovers I

Published May 1981 Obstetrics and Gynecology, 57(5), 661-665

Abstract

Marked improvement in the severe hypertension (250/150 mmHg) and hirsutism of a patient suffering from polycystic ovary syndrome was quickly achieved by the use of spironolactone 200 mg per day. Substitution of spironolactone with bromocriptine induced further amelioration of these symptoms and renewal of ovulatory cycles. These drugs may afford another mode of therapy in patients with polycystic ovary syndrome.

Topics

Therapeutics › Ovulation Agents › Dopamine Agonists · Reproductive Endocrinology › Ovarian Hormones › Androgens · Menstrual Cycle › Cycle Disorders › Ovulatory Disturbances

Blum et al. 1981, Blum 1981

Keywords

Adult, Bromocriptine/therapeutic Use, Female, Hirsutism/drug Therapy/etiology, Hormones/analysis, Humans, Hypertension/drug Therapy/etiology, Polycystic Ovary Syndrome/complications/drug Therapy, Spironolactone/therapeutic Use, Hormones, Spironolactone, Bromocriptine

Successful treatment of polycystic ovary syndrome with spironolactone or bromocriptine

Abstract

Topics

Related research

Therapeutic effects of spironolactone in polycystic ovary syndrome

SUN-109 Feasibility of Cyclic Progesterone and Spironolactone for PCOS-specific Health-Related Quality of Life—a six-month, Phase II, single arm, single center, open-label study

Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism

"Phase II 6-month Cyclic Progesterone/Spironolactone pilot Therapy Trial in Polycystic Ovary Syndrome : pre-post, single-arm feasibility study"

Keywords